DermatologyInvestigational

Leuphasyl (Pentapeptide-18)

Topical

Overview

Leuphasyl is a synthetic pentapeptide (Tyr-D-Ala-Gly-Phe-Leu) that mimics the N-terminal sequence of enkephalin and modulates acetylcholine receptor activity at the neuromuscular junction. It is proposed to stabilize the receptor in an inactive conformation, reducing the frequency of muscle fiber contraction without blocking neurotransmission.

Mechanism of Action

This mechanism is intended to yield a topical wrinkle-smoothing effect with cosmetic applications..

Research Summary & Key Findings

In vitro electrophysiology studies have shown that pentapeptide-18 reduces the amplitude of miniature endplate potentials in muscle preparations. Industry-supported trials have reported subjective improvements in periorbital and forehead lines after four weeks of topical use, though rigorous placebo-controlled designs and independent validation are limited. Clinical evidence in peer-reviewed dermatology literature remains sparse.

Clinical Status

Investigational

Leuphasyl (Pentapeptide-18) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Topical

Related Peptides in Dermatology

Find a Provider

Find a verified provider who offers Leuphasyl (Pentapeptide-18) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Leuphasyl (Pentapeptide-18).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.